CIK: 1242993 - Address: C/o Akcea Therapeutics, Inc., 22 Boston Wharf Road, 9Th Floor, Boston, MA 02210
19 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret1119-0-12922208
S%wins53584732374746

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

3/22/16 16:01
3/21/16
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFitzgerald Edward MMAOEVPS.d-356.4730-5-2320D-20-26-194411044-5-8101384
3/3/16 20:12
3/3/16
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFitzgerald Edward MMAOEVP,CFOS.d-596.1220-10-3315D-27-21-33-2153624184444469
2/3/16 16:37
2/1/16
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFitzgerald Edward MMAOEVP,CFOS.d-714.8123-15-5305D-32-21-38-27-19-14-926-9204093375
9/28/15 17:50
9/28/15
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFitzgerald Edward MMAOEVP,CFOS.d-576.4633-9-3289D-6425-20-20-7-15-15-8-7483-1114
9/1/15 17:14
8/28/15
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFitzgerald Edward MMAOEVP,CFOS-32910.0033-33-10280D-495219515264241-17-11-35-29-3014
7/16/15 17:25
7/16/15
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFitzgerald Edward MMAOEVP,CFOS.d-608.5421-7-2313D-605031-6-6-4552-3-14-23-38-18
5/4/15 16:36
5/1/15
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFitzgerald Edward MMAOEVP,CFOS.d-5288.8033-60-16306D-4722564256-13-3-1-3-12-26-21
3/23/15 18:02
3/20/15
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFitzgerald Edward MMAOEVP,CFOS.dm-848.7233-10-3305D-587513731860-2-282-7-24
2/4/15 16:16
2/2/15
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFitzgerald Edward MMAOEVP,CFOS.d-936.3333-15-5296D-68-6148-11160109314329-19
9/4/14 16:24
9/2/14
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFitzgerald Edward MMAOEVP,CFOS.d-3116.2233-50-15281D-70-68-28-64840-1-4-5183423
4/3/13 16:50
4/2/13
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFitzgerald Edward MMAOEVP,CFOS.d-9418.0433-5-3199D1339-24-10-17-21-11-5242169-47
3/26/13 16:57
3/26/13
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFitzgerald Edward MMAOEVP,CFOS.d-24218.7533-13-6192D18720-23-11-8-14-17-101-3-2-911-56
1/3/13 16:30
1/2/13
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFitzgerald Edward MMAOEVP,CFOS-50220.0833-25-13167D2886417-17-6-15-22-221-14-2-62
10/2/12 16:11
10/1/12
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFitzgerald Edward MMAOEVP,CFOS-60424.1733-25-12180D51417247332242424-7-17-29-22
7/5/12 16:23
7/2/12
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFitzgerald Edward MMAOEVP,CFOS-44117.6433-25-11205D5885248129847-1-603278
4/18/12 16:33
4/17/12
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFitzgerald Edward MMAOEVP,CFOS.d-60015.0033-40-19170D291824412-9-10-42520226628
4/3/12 17:56
4/3/12
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFitzgerald Edward MMAOEVP,CFOS.d-8416.1833-5-3168D353108853212741-1-8411474
3/26/12 16:41
3/23/12
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFitzgerald Edward MMAOEVP,CFOS.d-19915.4133-13-7160D36412763367744-1-2-774613
3/21/12 18:04
3/20/12
ARIAAriad Pharmaceuticals IncDEHealthBioPrdBiological Products, (No DiagFitzgerald Edward MMAOEVP,CFOS.d-46915.0233-31-18141D3591324633-452-335-3155727

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact